BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castillo-Castro C, Martagón-Rosado AJ, Ortiz-Lopez R, Garrido-Treviño LF, Villegas-Albo M, Bosques-Padilla FJ. Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome. World J Hepatol 2021; 13(11): 1494-1511 [PMID: 34904026 DOI: 10.4254/wjh.v13.i11.1494] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Yu S, Zhang Y, Zhang W, Zhong H, Lu X, Guan R. A review on the protective effect of active components in Antrodia camphorata against alcoholic liver injury. Journal of Ethnopharmacology 2023;300:115740. [DOI: 10.1016/j.jep.2022.115740] [Reference Citation Analysis]
2 Bocci G, Orlandi P, Manca ML, Rossi C, Salvati A, Brunetto MR, Solini A. Predictive Power of Tissue and Circulating Biomarkers for the Severity of Biopsy-Validated Chronic Liver Diseases. JCM 2022;11:5985. [DOI: 10.3390/jcm11205985] [Reference Citation Analysis]
3 Jackson KG, Way GW, Zhou H. Bile acids and sphingolipids in non-alcoholic fatty liver disease. Chin Med J (Engl) 2022. [PMID: 35788089 DOI: 10.1097/CM9.0000000000002156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Perez-Diaz-Del-Campo N, Martínez-Urbistondo D, Bugianesi E, Martínez JA. Diagnostic scores and scales for appraising Nonalcoholic fatty liver disease and omics perspective for precision medicine. Curr Opin Clin Nutr Metab Care 2022. [PMID: 35788123 DOI: 10.1097/MCO.0000000000000849] [Reference Citation Analysis]